Growth inhibition of subcutaneously transplanted human glioma by transfection-induced tumor necrosis factor-alpha and augmentation of the effect by gamma-interferon
- PMID: 7760098
- DOI: 10.1007/BF01052922
Growth inhibition of subcutaneously transplanted human glioma by transfection-induced tumor necrosis factor-alpha and augmentation of the effect by gamma-interferon
Abstract
Using subcutaneous solid tumors produced by U251-MG human glioma cells, we studied the in vivo transfection of the cells with the tumor necrosis factor-alpha (TNF-alpha) gene delivered by means of liposomes. When the tumor had become 7 mm in diameter, liposomes with entrapped TNF-alpha gene were injected into the center of the subcutaneous tumor. We found that mRNA of transfection-induced TNF-alpha, which was expressed in the tumor tissue, was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) method and its protein was demonstrated by enzyme-linked immunoassay. Growth of the tumor was inhibited when the injection was carried out five times at every other day. The growth-inhibitory effect by transfection-induced TNF-alpha was much remarkable as compared with exogenous TNF-alpha and the effect was enhanced by the intraperitoneal injection of gamma-interferon (IFN-gamma) 12 h prior to intratumoral injection of the liposomes.
Similar articles
-
Growth inhibition of glioma cells by liposome-mediated cell transfection with tumor necrosis factor-alpha gene--its enhancement by prior gamma-interferon treatment.Neurol Med Chir (Tokyo). 1992 Nov;32(12):873-6. doi: 10.2176/nmc.32.873. Neurol Med Chir (Tokyo). 1992. PMID: 1282676
-
Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.Br J Cancer. 1995 Nov;72(5):1165-72. doi: 10.1038/bjc.1995.481. Br J Cancer. 1995. PMID: 7577463 Free PMC article.
-
Basic study on gene therapy of human malignant glioma by use of the cationic multilamellar liposome-entrapped human interferon beta gene.Hum Gene Ther. 1999 Aug 10;10(12):1975-82. doi: 10.1089/10430349950017338. Hum Gene Ther. 1999. PMID: 10466631
-
[The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo].Strahlenther Onkol. 1997 Aug;173(8):407-14. doi: 10.1007/BF03038316. Strahlenther Onkol. 1997. PMID: 9289857 German.
-
Interferon-beta gene therapy for cancer: basic research to clinical application.Cancer Sci. 2004 Nov;95(11):858-65. doi: 10.1111/j.1349-7006.2004.tb02194.x. Cancer Sci. 2004. PMID: 15546502 Free PMC article. Review.
Cited by
-
Current and Future Gene Therapy for Malignant Gliomas.J Biomed Biotechnol. 2003;2003(1):25-34. doi: 10.1155/S1110724303209013. J Biomed Biotechnol. 2003. PMID: 12686720 Free PMC article.
-
A Rare but Morbid Occurrence: Development of Glioblastoma Multiforme During Tumor Necrosis Factor Inhibitor Therapy.Cureus. 2022 May 15;14(5):e25027. doi: 10.7759/cureus.25027. eCollection 2022 May. Cureus. 2022. PMID: 35719803 Free PMC article.
-
Adenovirus-mediated gene transduction of IkappaB or IkappaB plus Bax gene drastically enhances tumor necrosis factor (TNF)-induced apoptosis in human gliomas.Jpn J Cancer Res. 2000 Jan;91(1):41-51. doi: 10.1111/j.1349-7006.2000.tb00858.x. Jpn J Cancer Res. 2000. PMID: 10744043 Free PMC article.
-
Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo.J Neurooncol. 1998 Dec;40(3):197-204. doi: 10.1023/a:1006177328576. J Neurooncol. 1998. PMID: 10066091
-
Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats.J Neurooncol. 1999;45(3):209-18. doi: 10.1023/a:1006357424124. J Neurooncol. 1999. PMID: 10845391
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical